TABLE 1.
Patient characteristics
| Median age, years (range) | 63 (23–86) |
|
|---|---|---|
| N | % | |
| Male sex | 102 | 54 |
| Extrahepatic disease | 32 | 17 |
| DFI <12 | 86 | 46 |
| Tumor>5 cm | 62 | 33 |
| Multiple tumors | 88 | 47 |
| Node + primary | 124 | 66 |
| Synchronous disease | 15 | 8 |
| CEA >200 | 26 | 14 |
| CRS ≥3 | 49 | 26 |
| Any chemotherapy | 168 | 89 |
| 5-FU based regimen | 42 | 22 |
| Oxaliplatin based regimen | 13 | 7 |
| Irinotecan-based regimen | 102 | 54 |
| Posthepatectomy chemotherapy | 166 | 88 |
| Prehepatectomy chemotherapy | 47 | 25 |
| Regional chemotherapy | 48 | 26 |
| CD3 High | 38 | 20 |
| CD4 High | 42 | 23 |
| CD8 High | 36 | 19 |
| CD4:CD3 High | 56 | 30 |
| CD4:CD8 High | 107 | 57 |
| CD8:CD3 High | 49 | 26 |
| FoxP3 High | 26 | 14 |
| FoxP3:CD4 High | 122 | 65 |
| FoxP3:CD8 High | 105 | 56 |